Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Tissue Preparation Solution Enables Increased Efficiency for Molecular Pathology Laboratories

By LabMedica International staff writers
Posted on 27 Nov 2013
A new tissue preparation system now enables automated extraction of high-quality nucleic acids from fresh frozen tissues as well as from formalin-fixed paraffin embedded (FFPE) tissues. More...


Siemens Healthcare Sector (Malvern, PA, USA) now offers its “Tissue Preparation Solution,” which includes a Tissue Preparation System and the Versant Tissue Preparation Reagents kit. Fresh frozen (FF) tissues are typically used for quick diagnosis of patients undergoing surgery, for research, or for tissue collection and storage. Formalin-fixed, paraffin embedded tissue clinical samples are routinely prepared from tissues obtained from surgeries and biopsies. FF tissue samples usually require separate workflows and specific kits not compatible with FFPE tissues, making the integration of these two processes a challenge for molecular pathology labs. Now, the consolidation of both tissue types on the Siemens Tissue Preparation Solution provides the only automated solution currently available for standardized isolation of nucleic acids from both FF and FFPE tissue samples such as those obtained for in vitro diagnosis and research.

Before the introduction of this Siemens solution, laboratories were limited to systems that were either manual or only automated for certain steps of the process. “When compared to other manual and semi-automated procedures, the Siemens method really sets a new standard in quality and workflow efficiency for routine molecular pathology laboratories,” commented Manfred Dietel, MD, Director of Institute of Pathology, University Hospital, Charité Berlin (Germany).

Using magnetic particle-based isolation and proprietary bead technology, this solution provides a more efficient and reproducible process for the isolation of high-quality nucleic acids from FFPE tissue. It features an automated process including the integration of deparaffinization; eliminates centrifugation steps associated with deparaffinization; enables coextraction of DNA and RNA from a single extraction process with a single set of reagents; provides a standardized lysis step for all samples; delivers highly reproducible results; and processes up to 48 samples in about 4 hours. Laboratory safety and environmental quality are also enhanced as hazardous organic solvents are eliminated with the deparaffinization process.

Related Links:

Siemens Healthcare



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.